Literature DB >> 30532820

Recurrent very late thrombosis of drug-eluting stent: Optical coherence tomography findings.

Nobuaki Kobayashi1, Masamichi Takano2, Noritake Hata1, Masanori Yamamoto2, Takuro Shinada1, Yasuhiro Takahashi1, Kazunori Tomita1, Mitsunobu Kitamura1, Osamu Kurihara1, Kyoichi Mizuno3.   

Abstract

Very late stent thrombosis (VLST) after implantation of a drug-eluting stent (DES) is a rare but catastrophic complication and the mechanisms are not completely understood. We describe a 76-year-old patient with recurrent VLST of DES that developed at 13 and 23 months after the initial catheter procedure of DES implantation under the cessation of dual antiplatelet therapy. Optical coherence tomography (OCT) observation revealed small stent area of a DES. Based on the OCT findings, balloon angioplasty for expansion of the DES was performed and angiographic Thrombolysis In Myocardial Infarction grade 3 flow was subsequently obtained. Small stent area is considered a significant factor in acute or subacute stent thrombosis according to previous reports. The present report shows that small stent area of DES may be regarded as a key factor in recurrent VLST as well as cessation of dual antiplatelet therapy.

Entities:  

Keywords:  Drug-eluting stent; Optical coherence tomography; Very late stent thrombosis

Year:  2010        PMID: 30532820      PMCID: PMC6265143          DOI: 10.1016/j.jccase.2010.07.002

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  13 in total

1.  Stent underexpansion and residual reference segment stenosis are related to stent thrombosis after sirolimus-eluting stent implantation: an intravascular ultrasound study.

Authors:  Kenichi Fujii; Stéphane G Carlier; Gary S Mintz; Yi-ming Yang; Issam Moussa; Giora Weisz; George Dangas; Roxana Mehran; Alexandra J Lansky; Edward M Kreps; Michael Collins; Gregg W Stone; Jeffrey W Moses; Martin B Leon
Journal:  J Am Coll Cardiol       Date:  2005-04-05       Impact factor: 24.094

Review 2.  Very late thrombosis after drug-eluting stents.

Authors:  Fausto Feres; J Ribamar Costa; Alexandre Abizaid
Journal:  Catheter Cardiovasc Interv       Date:  2006-07       Impact factor: 2.692

3.  Late angiographic stent thrombosis (LAST) events with drug-eluting stents.

Authors:  Andrew T L Ong; Eugène P McFadden; Evelyn Regar; Peter P T de Jaegere; Ron T van Domburg; Patrick W Serruys
Journal:  J Am Coll Cardiol       Date:  2005-06-21       Impact factor: 24.094

4.  Correlates and long-term outcomes of angiographically proven stent thrombosis with sirolimus- and paclitaxel-eluting stents.

Authors:  Pramod K Kuchulakanti; William W Chu; Rebecca Torguson; Patrick Ohlmann; Seung-Woon Rha; Leonardo C Clavijo; Sang-Wook Kim; Ahn Bui; Natalie Gevorkian; Zhenyi Xue; Kimberly Smith; Jana Fournadjieva; William O Suddath; Lowell F Satler; Augusto D Pichard; Kenneth M Kent; Ron Waksman
Journal:  Circulation       Date:  2006-02-20       Impact factor: 29.690

5.  Recurrent late drug-eluting stent thrombosis upon discontinuation of antiplatelet therapy.

Authors:  Indu Varghese; Ayrin Ummer; Michele Roesle; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Cardiovasc Revasc Med       Date:  2008 Jul-Sep

6.  Primary and mid-term outcome of sirolimus-eluting stent implantation with angiographic guidance alone.

Authors:  Hajime Fujimoto; Susumu Tao; Tomotaka Dohi; Sachiko Ito; Jun Masuda; Mitani Haruo; Yo Fujimoto; Akiko Maehara; Tetsu Yamaguchi; Sugao Ishiwata; Minoru Ohno
Journal:  J Cardiol       Date:  2008-02-06       Impact factor: 3.159

7.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study.

Authors:  Joost Daemen; Peter Wenaweser; Keiichi Tsuchida; Linda Abrecht; Sophia Vaina; Cyrill Morger; Neville Kukreja; Peter Jüni; Georgios Sianos; Gerrit Hellige; Ron T van Domburg; Otto M Hess; Eric Boersma; Bernhard Meier; Stephan Windecker; Patrick W Serruys
Journal:  Lancet       Date:  2007-02-24       Impact factor: 79.321

8.  Incidence of thrombotic stent occlusion during the first three months after sirolimus-eluting stent implantation in 500 consecutive patients.

Authors:  Evelyn Regar; Pedro A Lemos; Francesco Saia; Muzaffer Degertekin; Kengo Tanabe; Chi-Hang Lee; Chourmouzios A Arampatzis; Angela Hoye; Georgios Sianos; Pim de Feyter; Willem J van der Giessen; Peter C Smits; Ron T van Domburg; Patrick W Serruys
Journal:  Am J Cardiol       Date:  2004-05-15       Impact factor: 2.778

9.  Recurrent very late drug-eluting stent thrombosis.

Authors:  Gabriele Pesarini; Mario Arieti; Roberta Spadaro; Corrado Vassanelli; Flavio Ribichini
Journal:  Cardiovasc Revasc Med       Date:  2009 Apr-Jun

10.  Very late thrombosis of sirolimus-eluting stent due to late malapposition: serial observations with optical coherence tomography.

Authors:  Takahiro Sawada; Junya Shite; Toshiro Shinke; Yusuke Tanino; Daisuke Ogasawara; Hiroyuki Kawamori; Hiroki Kato; Naoki Miyoshi; Naoki Yoshino; Ken-Ichi Hirata
Journal:  J Cardiol       Date:  2008-07-17       Impact factor: 3.159

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.